According to the Events page on Resverlogix's web site the company will be attending the European Atherosclerosis Society's 85th Anuual Congress in Prague from the 23rd until the 26th of this month....okay, that's one week and one day.

On the EAS Programme site Resverlgoix is not listed as either a Sponsor nor as an Exhibitor:

http://eas2017.com/sponsorship-and-exhibition/sponsors-exhibitors/

That's fine of course, just being there and having the opportunity to 'press the flesh' as it were can have its benefits....But that's not the big question for me.  My question is how can they afford to go given the financial state of the company.  

I do think they'll be there, I mean why go to the trouble of putting together an April 2017 fact sheet if they're not:

https://www.resverlogix.com/upload/media_element/273/01/rvx-fact-sheet---april-2017.pdf

That pdf even includes the cash balance of about $4.9 million as of Jan. 31st 2017 and the monthly cash burn rate of about $3.1 million....